U.S. markets closed

Orthofix Medical Inc. (OFIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
36.24-0.11 (-0.30%)
At close: 4:00PM EDT
36.24 0.00 (0.00%)
After hours: 04:04PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close36.35
Bid36.00 x 800
Ask36.30 x 800
Day's Range36.22 - 37.03
52 Week Range30.59 - 48.50
Avg. Volume85,309
Market Cap713.743M
Beta (5Y Monthly)1.14
PE Ratio (TTM)N/A
EPS (TTM)-0.42
Earnings DateNov 03, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est54.38
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-54% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for OFIX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Orthofix Medical Inc.
    OFIX: Lowering target price to $49.00ORTHOFIX MEDICAL INC has an Investment Rating of BUY; a target price of $49.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    10 days agoArgus Research
View more
  • MarketWatch

    Medical device maker Orthofix warns that Q3 revenue will rise only in low-single digits as COVID delays procedures

    Orthofix Medical Inc. said Wednesday it expects third-quarter revenue growth to come in at a low single-digit increase over the year-earlier period, hurt by the high volume of elective procedures that have been deferred or rescheduled in the U.S. and overseas because of the recent surge in cases of COVID-19 spurred by the highly transmissible delta variant. The Lewisville, Texas-based medical device maker said it remains confident in its strategy and ability to accelerate growth over time. The c

  • Business Wire

    Orthofix Provides Business Update

    LEWISVILLE, Texas, September 29, 2021--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today provided a business update. The Company has experienced the impact of higher than expected volumes of deferred or rescheduled elective procedures resulting from hospital procedural restrictions, both in the U.S. and internationally, associated with the recent surge in COVID-19 Delta variant cases. As a result, the Company expects revenue growth for

  • Zacks

    Orthofix (OFIX) Reaches Milestone for M6-C Disc Implants

    Orthofix (OFIX) reveals that more than 60,000 M6-C artificial cervical discs have been implanted worldwide.